Approval · Notice of Compliance 22566 · 2019
DOVATO: Notice of Compliance 22566
Issued August 22, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22566
- Date
- August 22, 2019
- Company
- Viiv Healthcare UlcMontreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DOVATO | 02491753 | Marketed |
Medicinal ingredients
- LAMIVUDINE 300 MG per TAB
- DOLUTEGRAVIR 50 MG per TAB